ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 308 filers reported holding ACADIA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.65 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $573,000 | +277.0% | 35,044 | +224.9% | 0.04% | +400.0% |
| Q2 2022 | $152,000 | -87.8% | 10,786 | -79.1% | 0.01% | -90.0% |
| Q1 2022 | $1,248,000 | +207.4% | 51,546 | +196.2% | 0.07% | +366.7% |
| Q4 2021 | $406,000 | -63.4% | 17,403 | -73.9% | 0.02% | -73.7% |
| Q3 2021 | $1,108,000 | -17.1% | 66,679 | +21.7% | 0.06% | 0.0% |
| Q2 2021 | $1,337,000 | +25.8% | 54,805 | +33.0% | 0.06% | -3.4% |
| Q1 2021 | $1,063,000 | +115.2% | 41,204 | +345.7% | 0.06% | +43.9% |
| Q4 2020 | $494,000 | +63.6% | 9,244 | +48.3% | 0.04% | -18.0% |
| Q2 2020 | $302,000 | -69.0% | 6,233 | -73.0% | 0.05% | -57.6% |
| Q1 2020 | $975,000 | +114.3% | 23,071 | +116.8% | 0.12% | +218.9% |
| Q4 2019 | $455,000 | +64.3% | 10,641 | +38.3% | 0.04% | +117.6% |
| Q3 2019 | $277,000 | – | 7,696 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 27,228,338 | $611,821,000 | 5.19% |
| First Washington CORP | 176,950 | $3,976,000 | 2.06% |
| SECTORAL ASSET MANAGEMENT INC | 783,424 | $17,604,000 | 1.93% |
| HARVEY CAPITAL MANAGEMENT INC | 219,042 | $4,921,000 | 1.84% |
| Ghost Tree Capital, LLC | 400,000 | $8,988,000 | 1.82% |
| Opus Point Partners Management, LLC | 36,733 | $825,000 | 1.62% |
| Palo Alto Investors LP | 1,650,780 | $37,093,000 | 1.59% |
| EMORY UNIVERSITY | 84,714 | $1,904,000 | 1.36% |
| GARRISON BRADFORD & ASSOCIATES INC | 69,000 | $1,550,000 | 1.32% |
| HealthCor Management, L.P. | 1,378,000 | $30,964,000 | 1.05% |